Tumor necrosis factor-related apoptosis-inducing ligand and its receptors in lung cancer therapy
赵雪强
Abstract
赵雪强
Abstract
Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) is a newly discovered apoptosis-inducing ligand that can induce apoptosis of cancer cells, but not of normal cells, through the activation of multiple signaling transduction pathways. By sensitizing lung cancer cells but not normal cells to apoptosis,TRAIL may become a new strategy for the treatment of lung cancer. Key words: Lung neoplasms ; TNF-related apoptosis-inducing ligand ; Apoptosis ;
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) is a newly discovered apoptosis-inducing ligand that can induce apoptosis of cancer cells, but not of normal cells, through the activation of multiple signaling transduction pathways. By sensitizing lung cancer cells but not normal cells to apoptosis,TRAIL may become a new strategy for the treatment of lung cancer. Key words: Lung neoplasms ; TNF-related apoptosis-inducing ligand ; Apoptosis ;
Key concepts: Apoptosis, Tumor necrosis factor alpha, Cancer research, Lung cancer, Receptor, Signal transduction, Necrosis, Cancer